E

Edesa Biotech

D
EDSA
USD
-0.17
(-7.173%)
Market Closed
61.000
حجم التداول
-2.225
الربح لكل سهم
-
العائد الربحي
-0.111223
P/E
7,144,255.80
حجم السوق
اليوم
-7.1730%
1 اسبوع
-19.708%
1 شهر
-45.409%
6 اشهر
-53.684%
12 اشهر
-13.725%
بداية السنة
-51.754%
كل الوقت
0%

Title:
Edesa Biotech

Sector:
Healthcare
Industry:
Biotechnology
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
هل تحتاج مساعدة او لديك استفسار؟